| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ADVAXIS INC COM NEW | 1,564,679 | 16,726,000 | 1.50% | ||
| 52 | TELIGENT INC NEW | 2,201,901 | 16,734,000 | 1.50% | ||
| 53 | MEDGENICS INC | 3,370,306 | 18,773,000 | 1.68% | ||
| 54 | OPHTHOTECH CORP | 410,000 | 18,913,000 | 1.70% | ||
| 55 | HORIZON PHARMA PLC | 1,050,000 | 19,037,000 | 1.71% | Call | |
| 56 | ARALEZ PHARMACEUTICALS INC | 4,406,990 | 21,374,000 | 1.92% | ||
| 57 | SOCIETAL CDMO INC | 2,450,086 | 21,659,000 | 1.94% | ||
| 58 | LION BIOTECHNOLOGIES INC COM | 2,638,259 | 21,713,000 | 1.95% | ||
| 59 | ANTARES PHARMA INC | 14,885,393 | 25,007,000 | 2.24% | ||
| 60 | ARATANA THERAPEUTICS INC | 3,085,979 | 28,885,000 | 2.59% | ||
| 61 | ENDO INTL PLC | 1,454,538 | 29,309,000 | 2.63% | ||
| 62 | SPDR SER TR | 500,000 | 33,145,000 | 2.97% | Put | |
| 63 | LA JOLLA PHARMACEUTICAL CO | 1,447,053 | 34,425,000 | 3.09% | ||
| 64 | HERON THERAPEUTICS INC COM | 2,850,000 | 49,105,000 | 4.40% | ||
| 65 | ANGIODYNAMICS INC | 2,890,679 | 50,703,000 | 4.54% | ||
| 66 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 4,394,464 | 54,491,000 | 4.88% | ||
| 67 | Progenics Pharmaceuticals Inc | 8,951,169 | 56,661,000 | 5.08% | ||
| 68 | NOVADAQ TECHNOLOGIES INC | 5,174,209 | 59,866,000 | 5.37% | ||
| 69 | RETROPHIN INC | 3,469,271 | 77,642,000 | 6.96% | ||
| 70 | HORIZON PHARMA PLC | 5,503,182 | 99,773,000 | 8.94% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-16-016379, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
